Integrin subunit beta 8 contributes to lenvatinib resistance in HCC von Hou, Wei, Bridgeman, Bryan, Malnassy, Greg, Ding, Xianzhong, Cotler, Scott J., Dhanarajan, Asha, Qiu, Wei

Volltext

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life von Guedj, Jeremie, Dahari, Harel, Rong, Libin, Sansone, Natasha D., Nettles, Richard E., Cotler, Scott J., Layden, Thomas J., Uprichard, Susan L., Perelson, Alan S.

Volltext

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial von Koh, Christopher, Dr, Canini, Laetitia, PhD, Dahari, Harel, PhD, Zhao, Xiongce, PhD, Uprichard, Susan L, PhD, Haynes-Williams, Vanessa, BSN, Winters, Mark A, MS, Subramanya, Gitanjali, MS, Cooper, Stewart L, MD, Pinto, Peter, MD, Wolff, Erin F, MD, Bishop, Rachel, MD, Ai Thanda Han, Ma, MD, Cotler, Scott J, Prof, Kleiner, David E, MD, Keskin, Onur, MD, Idilman, Ramazan, MD, Yurdaydin, Cihan, Prof, Glenn, Jeffrey S, MD, Heller, Theo, MBBch

Volltext

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago von Tatara, Eric, Gutfraind, Alexander, Collier, Nicholson T, Echevarria, Desarae, Cotler, Scott J, Major, Marian E, Ozik, Jonathan, Dahari, Harel, Boodram, Basmattee

Volltext

Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice von Duehren, Sarah, Uchida, Takuro, Tsuge, Masataka, Hiraga, Nobuhiko, Uprichard, Susan L., Etzion, Ohad, Glenn, Jeffrey, Koh, Christopher, Heller, Theo, Cotler, Scott J., Oka, Shiro, Chayama, Kazuaki, Dahari, Harel

Volltext

Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease von Kallwitz, Eric R, McLachlan, Alan, Cotler, Scott J

Volltext

Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling von Wang, Hao, Hou, Wei, Perera, Aldeb, Bettler, Carlee, Beach, Jordan R., Ding, Xianzhong, Li, Jun, Denning, Mitchell F., Dhanarajan, Asha, Cotler, Scott J., Joyce, Cara, Yin, Jun, Ahmed, Fowsiyo, Roberts, Lewis R., Qiu, Wei

Volltext

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients von Canini, Laetitia, Imamura, Michio, Kawakami, Yoshiiku, Uprichard, Susan L, Cotler, Scott J, Dahari, Harel, Chayama, Kazuaki

Volltext

Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago von Echevarria, Desarae, Gutfraind, Alexander, Boodram, Basmattee, Major, Marian, Del Valle, Sara, Cotler, Scott J, Dahari, Harel

Volltext

Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago von Cotler, Scott J., Hershow, Ronald, Wong, Shirley S., Tran, Phuong, Cheng, Anita, Dam, Lan, Cotler, Sheldon

Volltext

Physical activity and metabolic syndrome in liver transplant recipients von Kallwitz, Eric R., Loy, Veronica, Mettu, Praveen, Roenn, Natasha, Berkes, Jamie, Cotler, Scott J.

Volltext

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? von Guzman, Grace, Brunt, Elizabeth M, Petrovic, Lydia M, Chejfec, Gregorio, Layden, Thomas J, Cotler, Scott J

Volltext

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography von Shteyer, Eyal, Shekhtman, Louis, Zinger, Tal, Harari, Sheri, Gafanovich, Inna, Wolf, Dana, Ivgi, Hefziba, Barsuk, Rima, Dery, Ilana, Armoni, Daniela, Rivkin, Mila, Pipalia, Rahul, Cohen Eliav, Michal, Skorochod, Yizhak, Breuer, Gabriel S, Tur-Kaspa, Ran, Weil Wiener, Yonit, Stern, Adi, Cotler, Scott J, Dahari, Harel, Lurie, Yoav

Volltext

Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic von Malespin, Miguel, Harris, Ciel, Kanar, Ozdemir, Jackman, Kelly, Smotherman, Carmen, Johnston, Abbey, Ferm, Julie, de Melo, Silvio W, Scolapio, James S, Nelson, David R, Cotler, Scott J

Volltext

Letter to the Editor: Examining HBV‐RNA Kinetics During NA Treatment—Are NAs Multifunctional Antiviral Agents? von Dahari, Harel, Vaillant, Andrew, Cotler, Scott J.

Volltext

Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance von Shekhtman, Louis, Navasa, Miquel, Sansone, Natasha, Crespo, Gonzalo, Subramanya, Gitanjali, Chung, Tje Lin, Cardozo-Ojeda, E Fabian, Pérez-Del-Pulgar, Sofía, Perelson, Alan S, Cotler, Scott J, Forns, Xavier, Uprichard, Susan L, Dahari, Harel

Volltext

Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations von Shekhtman, Louis, Cotler, Scott J., Degasperi, Elisabetta, Anolli, Maria Paola, Uceda Renteria, Sara Colonia, Sambarino, Dana, Borghi, Marta, Perbellini, Riccardo, Facchetti, Floriana, Ceriotti, Ferruccio, Lampertico, Pietro, Dahari, Harel

Volltext

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography von Shteyer, Eyal, Shekhtman, Louis, Zinger, Tal, Harari, Sheri, Gafanovich, Inna, Wolf, Dana, Ivgi, Hefziba, Barsuk, Rima, Dery, Ilana, Armoni, Daniela, Rivkin, Mila, Pipalia, Rahul, Eliav, Michal Cohen, Skorochod, Yizhak, Breuer, Gabriel S, Tur-Kaspa, Ran, Wiener, Yonit Weil, Stern, Adi, Cotler, Scott J, Dahari, Harel, Lurie, Yoav

Volltext

Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action‐more detailed kinetic studies are needed von Dahari, Harel, Shlomai, Amir, Cotler, Scott J.

Volltext

Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation von Shekhtman, Louis, Cotler, Scott J., Ploss, Alexander, Dahari, Harel

Volltext